CE-Ventures backs UK's Oyster Therapeutics in $60 million Series A round

A venture capital unit tied to a major UAE conglomerate joined the financing of a British biotechnology firm. The company works on therapies that target protein breakdown to treat certain diseases. This step illustrates expanding UAE links to international healthcare innovation and research opportunities.
Read the full story at Wamda →
This is a short summary written by Entrepreneurs Of Dubai. The full article, its reporting and its images belong to Wamda.
